A Randomized Trial of Intensive Insulin Therapy in Newly Diagnosed Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine

Volumn 320, Issue 9, 1989, Pages 550-554

  Shah, Shirish C ^a   Malone, John ^a   Simpson, Norma E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATOR; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0024504171     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198903023200902     Document Type: Article

References (18)

1. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314: 1360–8.
2. Madsbad S, Krarup T, Faber of, Binder C, Regeur L. The transient effect of strict glycaemic control on B cell function in newly diagnosed type I (insulin-dependent) diabetic patients. Diabetologia 1982; 22: 16–20.
3. Perlman K, Ehrlich RM, Filler RM, Albisser AM. Sustained normoglycemia in newly diagnosed type I diabetic subjects: short-term effects and one-year follow-up. Diabetes 1984; 33: 995–1001.
4. Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A. Sustained insulin-induced remission of juvenile diabetes by means of an external artificial pancreas. Diabetologia 1978; 14: 223–7.
5. Duncan JA, Malone JI. An out-of-hospital approach to the newly diagnosed diabetic. Contemporary Pediatrics 1986; 3(2):79–86.
6. Brennan JR, Gebhart SS, Blackard WG. Pump-induced insulin aggregation: a problem with the Biostator. Diabetes 1985; 34: 353–9.
7. Horwitz DL, Rubenstein AH, Katz AI. Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine. Diabetes 1977; 26: 30–5.
8. Faber of, Binder C, Markussen J, et al. Characterization of seven C-peptide antisera. Diabetes 1978; 27: Suppl 1: 170–7.
9. Leahy JL, Weir GC. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia. Diabetes 1988; 37: 217–22.
10. Imamura T, Koffler M, Helderman JH, et al. Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes 1988; 37: 600–9.
11. Leahy JL, Bonnerweir S, Weir GC. Rapid reversal of B-cell defects caused by chronic hyperglycemia. Diabetes 1988; 37: Suppl 1: 6A. abstract.
12. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 1988; 319: 599–604.
13. Stiller CR, Dupre J, Gent M, et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–7.
14. Silverstein JH, Spillar RP, Maclaren NK, Decker P. Immunotherapy with steroids and Imuran (SI) in IDD: the importance of steroid induction. Diabetes 1987; 36: Suppl 1: 74A. abstract.
15. Bougneres PF, Carel JC, Castano L, et al. Factors associated with early remission of Type I diabetes in children treated with cyclosporine. N Engl J Med 1988; 318: 663–70.
16. Heimann P. Treatment of thyroiditis: observations from 207 cases collected during the period 1960–1968. Acta Med Scand 1970; 187: 323–9.
17. Palmer JP, Helquist S, Spinas GA, et al. Interleukin-1 stimulates or inhibits pancreatic beta cells depending upon beta cell activity. Diabetes 1988; 37: Suppl 1: 57A. abstract.
18. Gotfredsen CF, Buschard K, Frandsen EK. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933–5.